Spark Investment Management LLC Wave Life Sciences Ltd. Transaction History

Spark Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$7.44 - $11.29 $599,061 - $909,059	-80,519 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$6.94 - $14.22 $336,458 - $689,399	-48,481 Reduced 37.58%	80,519 $754,000
Q4 2019 Feb 11, 2020	SELL	$7.99 - $37.6 $844,543 - $3.97 Million	-105,700 Reduced 45.04%	129,000 $1.03 Million
Q3 2019 Nov 12, 2019	SELL	$19.17 - $27.4 $1.2 Million - $1.71 Million	-62,505 Reduced 21.03%	234,700 $4.82 Million
Q2 2019 Aug 12, 2019	BUY	$22.93 - $42.84 $621,517 - $1.16 Million	27,105 Added 10.04%	297,205 $7.75 Million
Q1 2019 May 07, 2019	BUY	$32.69 - $47.91 $3.47 Million - $5.09 Million	106,300 Added 64.9%	270,100 $10.5 Million
Q4 2018 Feb 12, 2019	BUY	$37.1 - $50.11 $304,220 - $410,902	8,200 Added 5.27%	163,800 $6.89 Million
Q2 2018 Aug 08, 2018	BUY	$33.85 - $50.65 $1.45 Million - $2.17 Million	42,900 Added 38.07%	155,600 $5.95 Million
Q1 2018 May 10, 2018	BUY	$32.45 - $54.7 $2.35 Million - $3.97 Million	72,500 Added 180.35%	112,700 $4.52 Million
Q4 2017 Feb 12, 2018	BUY	$21.8 - $39.35 $876,360 - $1.58 Million	40,200	40,200 $1.41 Million

192

122M

430K

330K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $872M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.